Effects of Lifestyle Intervention on Plasma Trimethylamine N-Oxide in Obese Adults

被引:57
|
作者
Erickson, Melissa L. [1 ]
Malin, Steven K. [2 ]
Wang, Zeneng [3 ]
Brown, J. Mark [3 ]
Hazen, Stanley L. [3 ]
Kirwan, John P. [1 ]
机构
[1] Louisiana State Univ, Pennington Biomed Res Ctr, Integrat Physiol & Mol Med Lab, Baton Rouge, LA 70808 USA
[2] Univ Virginia, Dept Kinesiol, Charlottesville, VA 22903 USA
[3] Cleveland Clin, Lerner Res Inst, Dept Cellular & Mol Med, Cleveland, OH 44106 USA
基金
美国国家卫生研究院;
关键词
trimethylamine N-oxide; obesity; caloric restriction; cardiovascular disease risk factors; gut microbiome; exercise; lifestyle intervention; GUT MICROBIOTA; PROATHEROGENIC METABOLITE; INSULIN-RESISTANCE; MORTALITY RISK; EXERCISE; PHOSPHATIDYLCHOLINE; CHOLINE; METAANALYSIS; CONTRIBUTES; DISEASE;
D O I
10.3390/nu11010179
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Accumulating evidence linking trimethylamine N-oxide (TMAO) to cardiovascular disease (CVD) risk has prompted interest in developing therapeutic strategies to reduce its production. We compared two lifestyle intervention approaches: hypocaloric versus eucaloric diet, combined with exercise, on TMAO levels in relation to CVD risk factors. Sixteen obese adults (66.1 +/- 4.4 years, BMI (body mass index): 35.9 +/- 5.3 kg/m(2), fasting glucose: 106 +/- 16 mg/dL, 2-h PPG (postprandial glucose): 168 +/- 37 mg/dL) were randomly assigned to 12 weeks of exercise (5 days/week, 80-85% HRmax (maximal heart rate)) plus either a hypocaloric (HYPO) (-500 kcal) or a eucaloric (EU) diet. Outcomes included plasma TMAO, glucose metabolism (oral glucose tolerance test (OGTT) and euglycemic-hyperinsulinemic clamps for glucose disposal rates (GDR)), exercise capacity (VO2max, maximal oxygen consumption), abdominal adiposity (computed tomography scans), cholesterol, and triglycerides. Results showed that body composition (body weight, subcutaneous adiposity), insulin sensitivity, VO2max, and cholesterol all improved (p < 0.05). HYPO decreased the percentage change in TMAO compared to an increase after EU (HYPO: -31 +/- 0.4% vs. EU: 32 +/- 0.6%, p = 0.04). Absolute TMAO levels were not impacted (HYPO: p = 0.09 or EU: p = 0.53 group). The change in TMAO after intervention was inversely correlated with baseline visceral adipose tissue (r = -0.63, p = 0.009) and GDR (r = 0.58, p = 0.002). A hypocaloric diet and exercise approach appears to be effective in reducing TMAO. Larger trials are needed to support this observation.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] The Association Between Lifestyle Interventions and Trimethylamine N-Oxide: A Systematic-Narrative Hybrid Literature Review
    Theodoridis, Xenophon
    Papaemmanouil, Androniki
    Papageorgiou, Niki
    Savopoulos, Christos
    Chourdakis, Michail
    Triantafyllou, Areti
    NUTRIENTS, 2025, 17 (07)
  • [2] Association of Urinary and Plasma Levels of Trimethylamine N-Oxide (TMAO) with Foods
    Lombardo, Mauro
    Aulisa, Giovanni
    Marcon, Daniele
    Rizzo, Gianluca
    Tarsisano, Maria Grazia
    Di Renzo, Laura
    Federici, Massimo
    Caprio, Massimiliano
    De Lorenzo, Antonino
    NUTRIENTS, 2021, 13 (05)
  • [3] Trimethylamine N-oxide: breathe new life
    Subramaniam, Saravanan
    Fletcher, Craig
    BRITISH JOURNAL OF PHARMACOLOGY, 2018, 175 (08) : 1344 - 1353
  • [4] The Association of Plasma Trimethylamine N-Oxide with Coronary Atherosclerotic Burden in Patients with Type 2 Diabetes Among a Chinese North Population
    Yu, Na
    Gu, Nan
    Wang, Yuxin
    Zhou, Bin
    Lu, Difei
    Li, Jianping
    Ma, Xiaowei
    Zhang, Junqing
    Guo, Xiaohui
    DIABETES METABOLIC SYNDROME AND OBESITY, 2022, 15 : 69 - 78
  • [5] Lifestyle Intervention Decreases Urine Trimethylamine N-Oxide Levels in Prepubertal Children with Obesity
    Leal-Witt, Maria J.
    Llobet, Marina
    Samino, Sara
    Castellano, Pol
    Cuadras, Daniel
    Jimenez-Chillaron, Josep C.
    Yanes, Oscar
    Ramon-Krauel, Marta
    Lerin, Carles
    OBESITY, 2018, 26 (10) : 1603 - 1610
  • [6] Targeting Trimethylamine N-Oxide: A New Therapeutic Strategy for Alleviating Atherosclerosis
    Jing, Lele
    Zhang, Honghong
    Xiang, Qiannan
    Shen, Liang
    Guo, Xiaoxia
    Zhai, Changlin
    Hu, Huilin
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [7] Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease
    Thomas, Minu S.
    Fernandez, Maria Luz
    CURRENT ATHEROSCLEROSIS REPORTS, 2021, 23 (04)
  • [8] Trimethylamine N-oxide: A harmful, protective or diagnostic marker in lifestyle diseases?
    Nowinski, Artur
    Ufnal, Marcin
    NUTRITION, 2018, 46 : 7 - 12
  • [9] Associations between physical activity and trimethylamine N-oxide in those at risk of type 2 diabetes
    Argyridou, Stavroula
    Bernieh, Dennis
    Henson, Joseph
    Edwardson, Charlotte L.
    Davies, Melanie J.
    Khunti, Kamlesh
    Suzuki, Toru
    Yates, Thomas
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (02)
  • [10] Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes
    Winther, Signe A.
    Ollgaard, Jens C.
    Tofte, Nete
    Tarnow, Lise
    Wang, Zeneng
    Ahluwalia, Tarunveer S.
    Jorsal, Anders
    Theilade, Simone
    Parving, Hans-Henrik
    Hansen, Tine W.
    Hazen, Stanley L.
    Pedersen, Oluf
    Rossing, Peter
    DIABETES CARE, 2019, 42 (08) : 1512 - 1520